Dr. kaku boston medical center

Drs. Michelle Kaku and K. H. Vincent Lau conduct both retrospective and prospective research at the Amyloidosis Center.

Kaku So-Armah | Profiles RNS - Boston University

They collaborate with other amyloidosis specialists at the center to examine characteristics of patients with hereditary amyloidosis using a large database of patients with hereditary amyloidosis, supported by a biorepository. They are also currentl sub-investigators in a multicenter clinical trial evaluating the efficacy of a novel treatment for hereditary transthyretin-mediated amyloid polyneuropathy.

Dr. Kaku has also studied how treatments for amyloidosis may cross the blood brain barrier in patients with central nervous system involvement of amyloidosis.

Research faculty

Michelle Kaku, MD
K. H. Vincent Lau, MD

Ongoing clinical studies:

“NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy” (NCT04136184)

HELIOS-A,A Phase 3 Global, R Dr.

Michelle Kaku, MD - Clinical Neurophysiologist in Boston ... BUQUR